India has traditionally been a significant market in the healthcare and pharmaceutical sector. Both products and services in this sphere have seen major growth over the years. The firm provides comprehensive insights into the key trends and risks operating in the pharmaceutical and bioscience sector as well as other healthcare bodies. The firm provides consultancy on strategic matters and handles litigation of complex nature relating to pharmaceuticals and health sector. The firm has an extensive experience in handling matters relating to the Drugs and Cosmetics Act, 1945 and Rules thereto, Food adulteration act etc. The firm is an advisor to a number of companies / firms engaged in business of Drugs and cosmetics in India.
The Firm has expertise in handling cases relating to Drugs and Cosmetics Act, 1940, arising out of Misbranded, spurious drugs and drugs not of standard quality. The approach of the firm also endorses that the IPR involved plays a critical and vital role for the players in this sector.